<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Mol Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">CMH</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Molecular Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2287-2728</issn>
      <issn pub-type="epub">2287-285X</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25320736</article-id>
      <article-id pub-id-type="pmc">4197181</article-id>
      <article-id pub-id-type="doi">10.3350/cmh.2014.20.3.310</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of small hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Young Mi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yoon</surname>
            <given-names>Ki Tae</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Mong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heo</surname>
            <given-names>Jeong</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Woo</surname>
            <given-names>Hyun Young</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Won</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Ki Tae Yoon. Department of Internal Medicine, Pusan National University Yangsan Hospital, Beomeo-ri, Mulgeum-eup, Yangsan 626-770, Korea. Tel: +82-55-360-2362, Fax: +82-55-360-1737, <email>ktyoon@pusan.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <volume>20</volume>
      <issue>3</issue>
      <fpage>310</fpage>
      <lpage>312</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>To the Editor,</p>
    <p>A 41-year-old man was admitted to our hospital for investigation of a liver mass with extensive lymph node (LN) enlargement that was detected during follow-up abdominal computed tomography (CT) for chronic viral hepatitis B. Laboratory investigations showed a serum alanine aminotransferase level was 31 IU/L (normal range 10-40 IU/L), the aspartate aminotransferase level was 23 IU/L (normal range 6-40 IU/L) and the &#x3B3;-glutamyltransferase level was 44 IU/L (normal range 5-63 IU/L). Alkaline phosphatase, total bilirubin and albumin levels were all within normal limits. The patient had an elevated serum &#x3B1;-fetoprotein level of 3580 ng/mL (normal range&#x2264;10 ng/mL) and a PIVKA-II level of 489 mAU/mL (normal range 0-40 mAU/mL); moreover, the carcinoembryonic antigen level was high level of 31.1 ng/mL (normal range 0-5 ng/mL). Serum hepatitis e antigen was negative and HBV PCR DNA level was 156 IU/mL. Abdominal CT showed hypodense mass, 2 cm, with necrosis at the medial portion, at the liver S7. Adding to this, CT demonstrated multiple conglomerated LN enlargement at the celiac axis, superior mesenteric artery (SMA), and para-aortic area (<xref ref-type="fig" rid="F1">Fig. 1</xref>). In addition to CT, magnetic resonance imaging (MRI) also showed 2 cm sized mass with necrosis at the medial portion, at the liver S7 and extensive LN enlargement. And FDG-PET/CT and chest CT were performed to evaluation of extrahepatic metastasis. FDG-PET/CT showed isometaoblic mass, S7 of the liver with extensive LN metastasis at neck, axilla, mediastinum, and retroperitoneum (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Based on these findings, we could suspected hepatic lymphoma or combined hepatocellular and lymphoma and liver biopsy was performed for confirmation of liver mass. However, because of no evidence of malignancy on histologic findings of liver mass, cervical excisional LN biopsy was conducted. Histologic findings revealed metastatic hepatocellular carcinoma (HCC) and we confirmed small hepatocellular carcinoma with extensive LN metastasis (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Base upon the diagnosis of HCC metastasis to the LN, we started therapy with sorafenib. Two months later after sorafenib administration, an abdomen CT revealed new multiple hypodense masses with central necrosis at the liver and unfortunately, the patient died 3.5 months after the detection of the liver mass.</p>
    <p>The rate of extrahepatic metastases from hepatocellular carcinoma (HCC) is relatively lower than that in other hepatic cancers.<xref rid="B1" ref-type="bibr">1</xref> Lymph node (LN) metastasis is observed in only 1.7% of patients undergoing surgery, but has been frequently observed in 30.7% of autopsies.<xref rid="B2" ref-type="bibr">2</xref> It has been reported that small HCC, less than 2 cm in diameter, constitute approximately 15.6% of resectable HCC.<xref rid="B3" ref-type="bibr">3</xref> Moreover, as a follow up of a high risk group of HCC using serum AFP and abdominal ultrasound is increased, early detection of resectable small HCC is increased so that in the case of small HCC, less than 2cm in diameter, is showing more than 50% of a 5-year survival rate.<xref rid="B4" ref-type="bibr">4</xref></p>
    <p>Because LN metastasis of small HCC are very rare and good prognosis, the clinical significance has not well investigated and the relationship between the type of a primary HCC lesion and type of accompanying lymph node metastasis has not been documented. There is one study to investigate the relationship between the type of a primary HCC and the type of accompanying lymph node metastasis. Although all of the primary HCC lesions are not small HCC, they suggested that we need to consider that the type of the primary lesion is related to the pattern of lymph node metastasis and systemic exploration for lymph node metastasis is important, even for patients with small nodular type HCC.<xref rid="B5" ref-type="bibr">5</xref></p>
    <p>Although diagnosis of small HCC has been increasing, there are lack of studies to investigate small HCC characteristics and prognosis. Therefore, further investigation should be needed to identify small HCC showing poor prognosis.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
    </fn-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>LN</term>
          <def>
            <p>lymph node</p>
          </def>
        </def-item>
        <def-item>
          <term>HCC</term>
          <def>
            <p>hepatocellular carcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uehara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ogiso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ohira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Igami</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Skip lymph node metastases from a small hepatocellular carcinoma with difficulty in preoperative diagnosis</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>345</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">12603540</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <collab>Liver Cancer Study Group of Japan</collab>
          <article-title>Survey and follow-up study of primary liver cancer in Japan: Report 17</article-title>
          <source>Acta Hepatol Jpn</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>117</fpage>
          <lpage>140</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <collab>Liver Cancer Study Group of Japan</collab>
          <article-title>Survey and follow-up study of primary liver cancer in Japan: Report 12</article-title>
          <source>Acta Hepatol Jpn</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>317</fpage>
          <lpage>330</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagashima</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Naruse</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Osada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical resection for small hepatocellular carcinoma</article-title>
          <source>Surgery</source>
          <year>1996</year>
          <volume>119</volume>
          <fpage>40</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">8560384</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Furuse</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Konishi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis</article-title>
          <source>Am J Clin Oncol</source>
          <year>2002</year>
          <volume>25</volume>
          <fpage>318</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">12040297</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Abdomen computed tomography showed (A) hypodense mass, in 2.5 cm diameter in arterial phase and (B) multiple conglomerated LNs enlargement at the celiac axis, SMA, and paraaortic area. FDG-PET/CT showed (C) increased uptake of multiple LNs such as both supraclavicular LNs and (D) multiple intraabdominal LNs (celiac axis, retropancreatic, right retrocaval, portocaval, aor tocaval, paraaor tic, common iliac bifurcation, both common iliac LN).</p>
      </caption>
      <graphic xlink:href="cmh-20-310-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Microscopic findings of excisioned neck LN shows that (A) lymph node is replaced by tumor cell nests consisting of thick trabeculae with central tumor necrosis (H&amp;E staining, &#xD7;40). (B) some tumor cells show positive reaction to HSA immunohistochemical staining. (observed under the high-power view (&#xD7;200) in a box).</p>
      </caption>
      <graphic xlink:href="cmh-20-310-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
